ReP USP - Resultado da busca

Artigo de periodico
Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks (2024)
Kumbhar, Popat; Kolekar, Kaustubh; Vishwas, Sukriti; Shetti, Priya; Kumbar, Vijay; Pinto, Terezinha de Jesus Andreoli ; Santos, Ana Cláudia Paiva ; Veiga, Francisco; Gupta, Guarav; Singh, Sachin Kumar; Dua, Kamal; Disouza, John; Patravale, Vandana
Source: Ageing Research Reviews. Unidade: FCF
Subjects: DEGENERAÇÃO MACULAR, NANOPARTÍCULAS, CÉLULAS-TRONCO, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUMBHAR, Popat et al. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Research Reviews, v. 98, p. 1-20 art. 102322, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102322. Acesso em: 15 nov. 2024.
APA
Kumbhar, P., Kolekar, K., Vishwas, S., Shetti, P., Kumbar, V., Pinto, T. de J. A., et al. (2024). Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Research Reviews, 98, 1-20 art. 102322. doi:10.1016/j.arr.2024.102322
NLM
Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Pinto T de JA, Santos ACP, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks [Internet]. Ageing Research Reviews. 2024 ; 98 1-20 art. 102322.[citado 2024 nov. 15 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102322
Vancouver
Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Pinto T de JA, Santos ACP, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks [Internet]. Ageing Research Reviews. 2024 ; 98 1-20 art. 102322.[citado 2024 nov. 15 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102322
Artigo de periodico
Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation (2024)
Bashir, Bushra; Alam, Shahbaz; Khandale, Nikhil; Birla, Devendra; Vishwas, Sukriti ; Pandey, Narendra Kumar; Gupta, Gaurav; Paudel, Keshav Raj ; Dureja, Harish; Kumar, Puneet; Singh, Thakur Gurjeet; Kuppusamy, Gowthamarajan; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Dhanasekaran, Muralikrishnan; Gulati, Monica; Dua, Kamal ; Singh, Sachin Kumar
Source: Ageing Research Reviews. Unidade: FCF
Subjects: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 15 nov. 2024.
APA
Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236
NLM
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 nov. 15 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Vancouver
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 nov. 15 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Artigo de periodico
Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems (2022)
Prasher, Parteek ; Sharma, Mousmee ; Singh, Sachin Kumar ; Gulati, Monica ; Jha, Niraj Kumar ; Gupta, Piyush Kumar ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Zacconi, Flavia ; Pinto, Terezinha de Jesus Andreoli ; Chan, Yinghan ; Liu, Gang; Paudel, Keshav Raj ; Hansbro, Philip Michael ; Oliver, Brian Gregory George; Dua, Kamal
Source: Chemico Biological Interactions. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, MUCO, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chemico Biological Interactions, v. 365, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2022.110048. Acesso em: 15 nov. 2024.
APA
Prasher, P., Sharma, M., Singh, S. K., Gulati, M., Jha, N. K., Gupta, P. K., et al. (2022). Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems. Chemico Biological Interactions, 365, 1-14. doi:10.1016/j.cbi.2022.110048
NLM
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, Pinto T de JA, Chan Y, Liu G, Paudel KR, Hansbro PM, Oliver BGG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems [Internet]. Chemico Biological Interactions. 2022 ; 365 1-14.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.cbi.2022.110048
Vancouver
Prasher P, Sharma M, Singh SK, Gulati M, Jha NK, Gupta PK, Gupta G, Chellappan DK, Zacconi F, Pinto T de JA, Chan Y, Liu G, Paudel KR, Hansbro PM, Oliver BGG, Dua K. Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems [Internet]. Chemico Biological Interactions. 2022 ; 365 1-14.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.cbi.2022.110048
Artigo de periodico
Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases (2019)
Mehta, Meenu; Deeksha; Sharma, Neha; Vyas, Manish; Khurana, Navneet; Maurya, Pawan Kumar; Singh, Harjeet; Pinto, Terezinha de Jesus Andreoli ; Dureja, Harish; Chellappan, Dinesh Kumar; Gupta, Gaurav; Wadhwa, Ridhima; Collet, Trudi; Hansbro, Philip M; Dua, Kamal; Satija, Saurabh
Source: Chemico Biological Interactions. Unidade: FCF
Subjects: ASMA, DOENÇAS RESPIRATÓRIAS, INFLAMAÇÃO, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Meenu et al. Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases. Chemico Biological Interactions, v. 304, p. 10-19, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.cbi.2019.02.021. Acesso em: 15 nov. 2024.
APA
Mehta, M., Deeksha,, Sharma, N., Vyas, M., Khurana, N., Maurya, P. K., et al. (2019). Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases. Chemico Biological Interactions, 304, 10-19. doi:10.1016/j.cbi.2019.02.021
NLM
Mehta M, Deeksha, Sharma N, Vyas M, Khurana N, Maurya PK, Singh H, Pinto T de JA, Dureja H, Chellappan DK, Gupta G, Wadhwa R, Collet T, Hansbro PM, Dua K, Satija S. Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases [Internet]. Chemico Biological Interactions. 2019 ; 304 10-19.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.cbi.2019.02.021
Vancouver
Mehta M, Deeksha, Sharma N, Vyas M, Khurana N, Maurya PK, Singh H, Pinto T de JA, Dureja H, Chellappan DK, Gupta G, Wadhwa R, Collet T, Hansbro PM, Dua K, Satija S. Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases [Internet]. Chemico Biological Interactions. 2019 ; 304 10-19.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.cbi.2019.02.021
Artigo de periodico
Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling (2019)
Lin, Chi-Chuan; Suen,Kin Man; Stainthorp,Amy; Wieteska,Lukasz; Biggs,George S.; Leitão, Andrei ; Montanari, Carlos Alberto ; Ladbury, John E.,
Source: Cancer Letters. Unidade: IQSC
Assunto: NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIN, Chi-Chuan et al. Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling. Cancer Letters, v. 457, p. 86-97, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.canlet.2019.05.008. Acesso em: 15 nov. 2024.
APA
Lin, C. -C., Suen, K. M., Stainthorp, A., Wieteska, L., Biggs, G. S., Leitão, A., et al. (2019). Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling. Cancer Letters, 457, 86-97. doi:10.1016/j.canlet.2019.05.008
NLM
Lin C-C, Suen KM, Stainthorp A, Wieteska L, Biggs GS, Leitão A, Montanari CA, Ladbury JE. Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling [Internet]. Cancer Letters. 2019 ;457 86-97.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.canlet.2019.05.008
Vancouver
Lin C-C, Suen KM, Stainthorp A, Wieteska L, Biggs GS, Leitão A, Montanari CA, Ladbury JE. Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling [Internet]. Cancer Letters. 2019 ;457 86-97.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.canlet.2019.05.008

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation

Countries of institutions of collaboration